VC
Vcanbio Cell & Gene Engineering Corp Ltd
🇨🇳XSHG.600645ChinaHealthcare
CNÂ¥28.43CNYup +0.23 (+0.82%)ClosedEnd of day6:54 PM
PriceCNÂ¥28.43+0.23 (+0.82%)
Profile
- Healthcare
- Biotechnology
- China
Identity
- Exchange
- Shanghai Stock Exchange . XSHG
- Type
- Stock
- ISIN
- CNE000000545
- CUSIP
- Not reported
Company
- Employees
- 2,014
- Headquarters
- Tianjin, China
- Website
- https://www.vcanbio.com
Market
- Shares outstanding
- 467.9M
- Market cap
- CNÂ¥13.3B
Highlights
- Market cap
- CNÂ¥13.3B
- EPS LTM
- CNÂ¥0.16calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 182.40calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 0%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CNÂ¥1.5B-5.92%down year on year
- Net income
- CNÂ¥72.94M-33.06%down year on year
- Gross margin
- 69.07%-0.23%down year on year
- Free cash flow
- CNÂ¥259.72M+31.47%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.